These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 12735786)

  • 1. Benefit-risk assessment of antileukotrienes in the management of asthma.
    García-Marcos L; Schuster A; Pérez-Yarza EG
    Drug Saf; 2003; 26(7):483-518. PubMed ID: 12735786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukotrienes in asthma: present situation.
    García-Marcos L; Schuster A
    Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma treatment: antileukotriene drugs.
    O'Byrne PM
    Can Respir J; 1998; 5 Suppl A():64A-70A. PubMed ID: 9753521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk-benefit assessment of antileukotrienes in asthma.
    Smith LJ
    Drug Saf; 1998 Sep; 19(3):205-18. PubMed ID: 9747667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New perspectives for asthma treatment: anti-leukotriene drugs.
    García-Marcos L; Schuster A
    Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileukotrienes in upper airway inflammatory diseases.
    Cingi C; Muluk NB; Ipci K; Şahin E
    Curr Allergy Asthma Rep; 2015 Nov; 15(11):64. PubMed ID: 26385352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antileukotrienes in asthma management.
    Tan RA
    Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma controller therapy: role of antileukotrienes, a new therapeutic class.
    Allegra L; Canonica GW; Donner CF; Fogliani V; Melillo G; Mistretta A; Paggiaro PL; Rossi GA; Sanguinetti CM; Vignola M
    Monaldi Arch Chest Dis; 1999 Apr; 54(2):136-45. PubMed ID: 10394828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
    Dunn CJ; Goa KL
    Drugs; 2001; 61(2):285-315. PubMed ID: 11270943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of leukotriene antagonists in childhood asthma.
    Krawiec ME; Wenzel SE
    Curr Opin Pediatr; 1999 Dec; 11(6):540-7. PubMed ID: 10590913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in antileukotriene therapy.
    Scadding GW; Scadding GK
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):370-6. PubMed ID: 20585242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
    Adkins JC; Brogden RN
    Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of antileukotriene use in asthma management.
    Polosa R
    Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prospects for long-term intervention in asthma with antileukotrienes.
    Smith LJ
    Clin Exp Allergy; 1998 Nov; 28 Suppl 5():154-63; discussion 171-3. PubMed ID: 9988462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
    Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
    Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antileukotrienes and Churg-Strauss syndrome].
    Guilpain P; Pagnoux C; Lhote F; Mouthon L; Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):890-4. PubMed ID: 17383148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B; Markham A
    Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma.
    Smith LJ
    BioDrugs; 2001; 15(4):239-49. PubMed ID: 11437689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.